About Us

The Human Vaccine Market size is estimated to grow by USD 29.1 billion at a CAGR of 9.49% between 2023 and 2028.

There has been a rise in public immunization programs funded by the governments of various countries which is significantly contributing to the market growth. For example, UIP was launched by the Government of India to provide vaccines against tuberculosis, polio, and other diseases for all Indian children. Moreover, UIP provided vaccines that included BCG for TB, DPT for diphtheria, pertussis, and tetanus, oral polio vaccine (OPV), and vaccines for measles. Hence, such factors are positively impacting the market.

With a rising prevalence of infectious diseases, the global vaccine market – currently valued at USD 77.6 billion – is forecast to reach USD 93.8 billion within the next five years showing an accelerated CAGR of 9.49% annually from 2024-2028. The Vaccines Forum will concentrate on the key trends and developments in the field of vaccine development, manufacturing, licensing, quality, regulations, upcoming technologies, clinical trials and post-trials. The event will have international as well as local exposure to give the attendees a holistic approach to the advancements in the vaccine sector as there will be industry experts, government officials, scientists, and analytical experts addressing the participants. It will be a great opportunity for the attendees to network and learn from the top industry players and learn about new technologies like AI, machine learning, single use systems etc.